Literature DB >> 7871397

[Special aspects of malnutrition in geriatrics].

W O Seiler1, H B Stähelin.   

Abstract

In 1992 people aged 65 years and over represented 11.9% (men) and 17.2% (women) of the Swiss population, and in 2000 the average 65-year-old man or woman can expect to live about 12 more years. Old age is characterized by multimorbidity, an accumulation of chronic conditions and diseases, and by social isolation. Multimorbidity and isolation (living alone) are the major risk factors for malnutrition. 30-60% of all persons aged 65 years and over show one or more subnormal nutritional parameters. The unspecific and oligosymptomatic clinical picture of malnutrition in the elderly often hinders an early diagnosis, and malnutrition is often misdiagnosed as "wasting away syndrome" of the old. Thus, the nutritional assessment of the elderly should become a routine diagnostic procedure. Detection of malnutrition involves assessment of nutritional parameters including history (eating habits, appetite), anthropometric measurements (weight, height, body mass index, triceps skinfold, midarm circumference), serum proteins (albumin, transferrin, prealbumin, cholinesterase, retinol binding protein), vitamins (B12, folic acid, B1, B2, B6, C and D), minerals and trace elements (zinc, magnesium, calcium, iron), immunologic skin tests and lymphocyte count. Depending on the history and the clinical symptoms, a selected number of these nutritional parameters are assessed. When assessing the nutritional status of the elderly it is important to define the etiologic factors involved. Thus, treatment of underlying causes and refeeding can be streamlined, so that maximum benefit can be obtained for the quality of life of the elderly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7871397

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  2 in total

1.  Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.

Authors:  Bo Zhang; Cheng Shen; Jie Jin; Yi Song; Zheng Zhao; Xiaochun Zhang; Gang Wang; Yu Fan; Yue Mi; Shuai Hu; Yun Cui; Liqun Zhou; Zhisong He; Wei Yu; Wenke Han
Journal:  Int Urol Nephrol       Date:  2016-08-23       Impact factor: 2.370

2.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.